Rolapitant (INN, [2] trade name Varubi / v ə ˈ r uː b i / və-ROO-bee in the US and Varuby in the European Union) is a drug originally developed by Schering-Plough and licensed for clinical development by Tesaro, which acts as a selective NK 1 receptor antagonist (antagonist for the NK 1 …

2024年10月28日 · What is rolapitant? Rolapitant is used together with other medicines to prevent nausea and vomiting caused by cancer chemotherapy. Rolapitant may also be used for purposes not listed in this medication guide.

Rolapitant is a substance P/neurokinin 1 (NK1) receptor antagonist. It works by blocking the signals to the brain that cause nausea and vomiting. This medicine is available only with your doctor's prescription.

2024年11月27日 · Varubi (rolapitant) is used to treat chemotherapy-induced nausea and vomiting. Includes Varubi side effects, interactions and indications.

Rolapitant is a potent, highly selective, long-acting Neurokinin-1 (NK-1) receptor antagonist approved for the prevention of delayed chemotherapy-induced nausea and vomiting (CINV) in adults.

Rolapitant is in a class of medications called antiemetics. It works by blocking the action of neurokinin and substance P, natural substances in the brain that cause nausea and vomiting. How should this medicine be used? Rolapitant comes as a tablet to take by mouth.

Rolapitant is used with other medications to help prevent delayed nausea and vomiting caused by cancer drug treatment (chemotherapy). It works by blocking one of the body's natural...

Indicated in combination with other antiemetic agents (eg, dexamethasone and 5HT-3 antagonist) in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses...

2023年7月24日 · Rolapitant is an antiemetic medication used to prevent delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy treatment in adults. Rolapitant is usually administered in combination with another type of antiemetic, serotonin 5-HT3 receptor antagonist and a corticosteroid, dexamethasone. Rolapitant is used ...

Used in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.